Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ROPEGINTERFERON ALFA-2B-NJFT for Essential thrombocythaemia: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 123 adverse event reports in the FDA FAERS database where ROPEGINTERFERON ALFA-2B-NJFT was used for Essential thrombocythaemia.

Most Reported Side Effects for ROPEGINTERFERON ALFA-2B-NJFT

Side Effect Reports % Deaths Hosp.
Fatigue 298 21.2% 0 13
Off label use 210 15.0% 4 24
Pruritus 152 10.8% 0 9
Headache 135 9.6% 0 8
Inappropriate schedule of product administration 103 7.3% 0 9
Product dose omission issue 99 7.1% 1 7
Influenza like illness 97 6.9% 0 4
Nausea 91 6.5% 1 3
Diarrhoea 89 6.3% 0 11
Arthralgia 88 6.3% 0 10
Pain 82 5.8% 0 7
Platelet count increased 75 5.3% 0 6
Haematocrit increased 74 5.3% 0 3
Dizziness 70 5.0% 0 5
Injection site erythema 68 4.8% 0 4

Other Indications for ROPEGINTERFERON ALFA-2B-NJFT

Polycythaemia vera (1,011) Product used for unknown indication (156) Myeloproliferative neoplasm (54) Polycythaemia (23) Cutaneous t-cell lymphoma (12) Myelofibrosis (8)

Other Drugs Used for Essential thrombocythaemia

RUXOLITINIB (1,788) ANAGRELIDE (797) HYDROXYUREA (629) PEGINTERFERON ALFA-2A (259) ASPIRIN (77) PACRITINIB (66) LENALIDOMIDE (41) FEDRATINIB (28) XAGRID (27) ASPIRIN DL-LYSINE (22)

Related Pages

ROPEGINTERFERON ALFA-2B-NJFT Full Profile All Essential thrombocythaemia Drugs ROPEGINTERFERON ALFA-2B-NJFT Demographics ROPEGINTERFERON ALFA-2B-NJFT Timeline